Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. is a manufacturer of products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.

Bio-Rad Laboratories, Inc.
Public
Traded as
  • NYSE: BIO (Class A)
  • S&P 500 component
IndustryMedical laboratories,
life science research
Founded1952
Founders
  • David Schwartz
  • Alice Schwartz
Headquarters
Hercules, California
,
United States
Area served
Global
Key people
  • Norman Schwartz
  • (President & CEO)
  • Andy Last
  • (Chief Operating Officer)
  • Giovanni Magni
  • (Chief Strategy Officer)
  • Ilan Daskal
  • (CFO)[1]
  • Michael Crowley
  • (EVP Global Commercial Operations)
  • Annette Tumolo
  • (President, Life Science Group)
  • Dara Wright
  • (President, Clinical Diagnostics Group)
Revenue US$2.31 billion (2019)
US$229.66 million (2019)
US$1.76 billion (2019)
Total assets US$8.01 billion (2019)
Total equity US$5.76 billion (2019)
Number of employees
8,120 (2019)
Websitebio-rad.com
Footnotes / references
[2]

Business segments

Bio-Rad’s life science products primarily include instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. These products are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.[3]

Bio-Rad’s diagnostic products and systems use a range of technologies and provide clinical information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets. These products are used to support the diagnosis, monitoring, and treatment of diseases and other medical conditions.

History
Bio-Rad Laboratories is based in Hercules, California, located along the Bay.

Bio-Rad Laboratories was founded in 1952 by David Schwartz and his wife Alice, both recent graduates of the University of California, Berkeley.

In January 2013, Bio-Rad purchased AbD Serotec, a division of MorphoSys AG.[4] This added Serotec’s more than 15,000 antibodies, kits, and accessories to Bio-Rad’s portfolio of research and clinical diagnostic products.[5]

In 2011, Bio-Rad acquired a new technology, droplet digital PCR. Droplet digital PCR allows scientists to distinguish rare sequences in tumors and precisely measure copy number variation.[6]

Today the company has direct distribution channels in over 35 countries outside the United States through subsidiaries whose focus is sales, customer service and product distribution. In some locations outside and inside these 35 countries, sales efforts are supplemented by distributors and agents.[7]

Vickers Instruments

In 1989, Bio-Rad purchased the British instrument-making firm, Vickers (1828 - 1999), apart from their defense products, which were sold to British Aerospace. This company had been known until 1963 as Cooke, Troughton & Simms. Cooke, Troughton & Simms was formed in 1922 by the merging of T. Cooke & Sons, a York-based instrument maker founded in 1837 by the self-taught schoolmaster Thomas Cooke, and the London instrument-maker, Troughton & Simms founded in 1828 by Edward Troughton who began his apprenticeship in 1773.[8]

Bioradiations

Bioradiations is an online magazine created by Bio-Rad that offers researchers case studies, whitepapers, tips, techniques, and topics related to Bio-Rad products and services. Bioradiations began as a print magazine that was launched in 1965[9] and was in continuous publication until 2011.

See also

References
  1. "CFO Moves: Alcon, Bio-Rad Laboratories, CMC Markets". The Wall Street Journal. Retrieved Nov 19, 2019.
  2. "US SEC: 2019 Form 10-K Bio-Rad Laboratories, Inc". U.S. Securities and Exchange Commission. March 2, 2020. Retrieved Jun 25, 2020.
  3. Bio-Rad Annual Report 2016 | http://www.bio-rad.com/webroot/web/pdf/corporate/annualreport/Annual_Report_2016.pdf
  4. Mark, Barry. "Revenue Update on Bio-Rad Laboratories, Inc". Markets Bureau. Archived from the original on 2 April 2015. Retrieved 4 March 2015.
  5. "Bio-Rad Acquires AbD Serotec from MorphoSys". Genetic Engineering & Biotechnology News. 17 December 2012.
  6. Bio-Rad Annual Report 2011
  7. Bio-Rad Annual Report 2016
  8. "Vickers Instruments - Borthwick Institute for Archives, The University of York". www.york.ac.uk. Retrieved 2019-11-27.
  9. BioCompare

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.